METROPOLIS Stock Overview
Metropolis Healthcare Limited provides diagnostic services in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Metropolis Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,841.00 |
| 52 Week High | ₹1,933.50 |
| 52 Week Low | ₹1,209.25 |
| Beta | 0.30 |
| 1 Month Change | 14.92% |
| 3 Month Change | 18.12% |
| 1 Year Change | 51.17% |
| 3 Year Change | -24.57% |
| 5 Year Change | 94.23% |
| Change since IPO | 91.80% |
Recent News & Updates
Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E
Mar 28
Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal
Jan 13Recent updates
Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E
Mar 28Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal
Jan 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion
Dec 23Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?
Sep 08Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital
Jun 20Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively
Mar 14Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00
Feb 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price
Sep 25Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?
Sep 10Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet
Jun 07Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
May 16Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?
Mar 17Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
Jan 29Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?
Dec 14Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns
Oct 12Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?
Aug 27Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean
Jul 06I Ran A Stock Scan For Earnings Growth And Metropolis Healthcare (NSE:METROPOLIS) Passed With Ease
May 28Metropolis Healthcare (NSE:METROPOLIS) Is Aiming To Keep Up Its Impressive Returns
Mar 29Does Metropolis Healthcare's (NSE:METROPOLIS) Share Price Gain of 15% Match Its Business Performance?
Mar 11Trade Alert: The Chief Executive Officer Of Metropolis Healthcare Limited (NSE:METROPOLIS), Vijender Singh, Has Sold Some Shares Recently
Feb 24Metropolis Healthcare Limited (NSE:METROPOLIS) Passed Our Checks, And It's About To Pay A ₹8.00 Dividend
Feb 12Metropolis Healthcare Limited's (NSE:METROPOLIS) 0.4% Dividend Yield Looks Pretty Interesting
Feb 09
Is Metropolis Healthcare Limited (NSE:METROPOLIS) Popular Amongst Insiders?
Jan 25Is Metropolis Healthcare Limited's (NSE:METROPOLIS) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Jan 10Metropolis Healthcare (NSE:METROPOLIS) Knows How to Allocate Capital
Dec 26The Metropolis Healthcare (NSE:METROPOLIS) Share Price Is Up 54% And Shareholders Are Holding On
Dec 11Shareholder Returns
| METROPOLIS | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 5.4% | -0.8% | 1.8% |
| 1Y | 51.2% | 65.6% | 46.4% |
Return vs Industry: METROPOLIS underperformed the Indian Healthcare industry which returned 61.4% over the past year.
Return vs Market: METROPOLIS exceeded the Indian Market which returned 46.1% over the past year.
Price Volatility
| METROPOLIS volatility | |
|---|---|
| METROPOLIS Average Weekly Movement | 5.0% |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: METROPOLIS has not had significant price volatility in the past 3 months.
Volatility Over Time: METROPOLIS's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 4,300 | Surendran Chemmenkotil | www.metropolisindia.com |
Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates.
Metropolis Healthcare Limited Fundamentals Summary
| METROPOLIS fundamental statistics | |
|---|---|
| Market cap | ₹94.31b |
| Earnings (TTM) | ₹1.25b |
| Revenue (TTM) | ₹11.59b |
75.6x
P/E Ratio8.1x
P/S RatioIs METROPOLIS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| METROPOLIS income statement (TTM) | |
|---|---|
| Revenue | ₹11.59b |
| Cost of Revenue | ₹2.56b |
| Gross Profit | ₹9.03b |
| Other Expenses | ₹7.79b |
| Earnings | ₹1.25b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 24.35 |
| Gross Margin | 77.94% |
| Net Profit Margin | 10.76% |
| Debt/Equity Ratio | 22.0% |
How did METROPOLIS perform over the long term?
See historical performance and comparison